
As per Data Bridge Market Research analysis, the cholesterol testing products and services market was valued at USD 10.95 billion in 2025 and is projected to reach USD 14.47 billion by 2033, growing at a CAGR of 3.55% from 2026 to 2033.
The market is experiencing consistent growth driven by the rising prevalence of cardiovascular diseases, increasing emphasis on preventive healthcare, growing geriatric population, and continuous advancements in cholesterol testing technologies and diagnostic solutions.
The increasing need for early detection and regular monitoring of high cholesterol, combined with growing awareness of cardiovascular risk factors such as obesity, diabetes, physical inactivity, and hypertension, is encouraging greater adoption of cholesterol testing products and services. Testing kits, laboratory-based tests, and convenient point-of-care and home-testing solutions are increasingly supporting accessible and routine cholesterol monitoring.

